Product Images Lumason

Lumason is an injectable suspension containing sulfur hexafluoride, lipid-type A, and microspheres. It is intended for intravenous or intravesical use only after reconstitution. Each kit contains one vial of Lumason, one pre-filled Syringe containing sodium chloride injection, and one mini-spike. The kit components contain sulfur hexafluoride and various microspheres. The package insert provides recommended dosage and reconstitution instructions. The product is manufactured by Bracco Diagnostics and is for a single-use only.*

Lumason is a medication available only on prescription, which comes in the form of a lyophilized powder for injectable suspension. It is made up of sulfur hexafluoride lipid-type A microspheres, with a content of 60.7mg of sulfur hexafluoride per vial, along with 25mg of lipid-type A. In addition, the Lumason pack contains a pre-filled syringe, containing 5mL of Sodium Chloride 0.8% Injection USP for use during reconstitution, as well as one mini-spike. NovaPlus is also mentioned, which appears to contain a pre-filled syringe with 5mg of polyethylene. There is a warning that Lumason is only suitable for intravenous or intravesical use and should not be used without reconstitution.*

Lumason is an injectable suspension containing sulfur hexafluoride lipid-type A microspheres. It is for intravenous or intravesical use only after reconstitution. Each vial contains sterile lyophilized powder of lipid-type A blend consisting of .19 mg distereaylphosphaticyichoine and .19 g dipaimitoylphosphatidyghyceral sodium, 2455 mg polyethylene glycol 000 and 0.4 mg paimitic acid. The headspace of the vial contains 807 mg sulfur hexafluoride. Each Lumason 20-vial pack contains 20 single-patient use vials of Lyumason lyophilized powder for injectable suspension, 507 mg sulfur hexafluoride/25 mg lipid-type A, and 20 mini spikes and D labels. The recommended dosage should be checked from the prescribed information. Store Lumason at 25°C with excursions permitted up to 15° to 30°C. The product is manufactured for Bracco Diagnostics Inc. by Bracco Suisse SA. The product is registered under the trademark Novaplus.*

Lumason is a prescription drug with the NDC number 0270-7099-73. It is administered via intravenous or intravesical use after reconstitution with Sodium Chioride 0.3% Injection, USP. The reconstituted solution has to be used within 3 hours of reconstitution. Lumason needs to be stored at 25°C with excursions permitted to 15°-30°C (56° to 86°F) and is for single use only. No additional information related to the drug's effectiveness or benefits has been mentioned.*

Lumason® is a sulfur hexafluoride lipophilized powder for injectable suspension with NDC code 0270-7097-08. It is intended for intravenous or intravesical use after reconstitution with 0.9% Sodium Chloride Injection, USP. The reconstituted solution should be used for a single patient and any unused portion should be discarded within 3 hours. Lumason® should be stored at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Additional information such as date and time of the solution preparation, lot number, and expiration date is also provided.*

The text provides a list of medical items which includes 20 glass vials, 20 mini-spikes, and 20 peel-off syringe labels. The name "Lumason" is also mentioned, but no further context is provided.*

The text describes medical equipment including a glass vial, a prefilled syringe with diluent, a mini-spike, and a plunger rod. These items are specifically related to a product called Lumason.*